| Literature DB >> 24049073 |
Roxane Lestini1, Sergey P Laptenok, Joëlle Kühn, Mark A Hink, Marie-Claire Schanne-Klein, Ursula Liebl, Hannu Myllykallio.
Abstract
Hef is an archaeal member of the DNA repair endonuclease XPF (XPF)/Crossover junction endonuclease MUS81 (MUS81)/Fanconi anemia, complementation group M (FANCM) protein family that in eukaryotes participates in the restart of stalled DNA replication forks. To investigate the physiological roles of Hef in maintaining genome stability in living archaeal cells, we studied the localization of Hef-green fluorescent protein fusions by fluorescence microscopy. Our studies revealed that Haloferax volcanii Hef proteins formed specific localization foci under regular growth conditions, the number of which specifically increased in response to replication arrest. Purification of the full-length Hef protein from its native host revealed that it forms a stable homodimer in solution, with a peculiar elongated configuration. Altogether our data indicate that the shape of Hef, significant physicochemical constraints and/or interactions with DNA limit the apparent cytosolic diffusion of halophilic DNA replication/repair complexes, and demonstrate that Hef proteins are dynamically recruited to archaeal eukaryotic-like chromatin to counteract DNA replication stress. We suggest that the evolutionary conserved function of Hef/FANCM proteins is to enhance replication fork stability by directly interacting with collapsed replication forks.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24049073 PMCID: PMC3905845 DOI: 10.1093/nar/gkt816
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Haloferax volcanii strains used
| Strain | Relevant genotype | Source or reference |
|---|---|---|
| H26 | Δ | ( |
| H178 | Δ | ( |
| H358 | Δ | ( |
| H1209 | Δ | ( |
| HvRL8 | Δ | (pTA370) |
| HvRL26 | Δ | HvRL8 × pRL6 |
| HvRL37 | Δ | (pRL12) |
| HvRL61 | Δ | (pTA225) |
| HvRL65 | Δ | (pRL32) |
| HvRL66 | Δ | (pRL34) |
Plasmids used
| Plasmid | Relevant properties | Source or reference |
|---|---|---|
| pTA131 | Integrative vector based on pBluescript II, with | ( |
| pTA225 | pGB70with Δ | ( |
| pTA370 | pTA131 with 1.6 kb Δ | ( |
| pTA963 | Overexpression vector with | ( |
| pTA1097 | pTA131 with 4.7 kb | ( |
| pJAM1020 | Apr Novr, smRSGFP expressed in | ( |
| pRL6 | pTA963 with a PciI-EcoRI | This study |
| pRL12 | pTA1097 with insertion of a | This study |
| pRL29 | pBluescript vector with a synthetic | This study |
| pRL32 | Integrative vector pTA131 with insertion of flanking regions of | This study |
| pRL34 | Integrative vector pTA131 with insertion of flanking regions of | This study |
Oligonucleotides used
| Primer | Sequence (5′–3′) | Relevant properties | Plasmid |
|---|---|---|---|
| RL31 | Amplification of | ||
| RL32 | Amplification of | ||
| RL33 | Amplification of | ||
| RL34 | Amplification of | ||
| RL39 | pRL6 | ||
| Hef 3′ R | pRL6 | ||
| RL54 | pRL12 | ||
| RL55 | pRL12 | ||
| RL85 | pRL32/34 | ||
| RL85bis | pRL34 | ||
| RL108 | pRL32/34 | ||
| RL109 | pRL34 | ||
| RL114 | pRL32/34 | ||
| RL115 | pRL32/34 | ||
| RL116 | pRL32/34 | ||
| RL117 | pRL34 | ||
| RL119 | pRL32 |
aRestriction endonuclease sites used in cloning are underlined, 15 bases overlap with flanking fragments are shown in bold.
Figure 1.gfp-fused hef allele construction and functional characterization. (A) Representation of the chromosomal locus of the hef::gfp allele. The regions of homology between the plasmid and the chromosome used for pop-in/pop-out gene replacement are represented by white boxes (Upstream region and downstream region). The sequence of the 3′ end of the H.volcanii hef gene fused to the gfp gene is shown. BlpI* refers to the inactivated restriction site after cleavage and processing of the cohesive extremity into blunt end. (B) Strains streaked on YPC control plates and YPC plates containing 0.02 µg/ml MMC after 7 days of incubation. (C) Fraction of living cells in response to increasing concentrations of aphidicolin for WT (black square), hef-deleted (black triangle) and hef+::gfp+ cells (black circle). Error bars represent standard deviations of at least three independent experiments. (D) Generation times (± SEM) of WT and hef+::gfp+ cells, and hef+::gfp+ in a hjc-deleted background.
Figure 2.In vitro characterization of Hef oligomeric state and shape. (A) 0.75 and 2.25 µg of purified H.volcanii Hef holoprotein, separated on 4–12% SDS-PAGE. (B) Sedimentation velocity analysis of HvoHef at 20°C. The data recorded at 1 mg/ml in 2M KCl with 10 mM HEPES (pH 7.0) were fitted using SEDFIT software (22). (C) Sedimentation equilibrium analysis of HvoHef at 20°C. A HvoHef sample at 1 mg/ml in 2M KCl with 10 mM HEPES (pH 7.0) was used. Data recorded at 3564g (black square), 5132g (black triangle) and 10 649g (black circle) were fitted using species analysis model 1 of the SEDPHAT software.
Figure 3.In vivo localization of GFP-labeled Hef in response to aphidicolin exposure. A total of 23 760 foci within 13 666 control cells and 15 299 foci within 3721 APD-treated cells were analyzed. (A) Pictures of DIC and GFP signal of hef+::gfp+ (HvRL37) cells under control conditions and after exposure to 5 µg/ml aphidicolin. Bar equals 10 µm. (B) Average cell surface of HvRL37 cells in response to increasing concentrations of aphidicolin. (C) Mean number of GFP-Hef labeled fluorescence foci in HvRL3) cells in response to increasing concentrations of aphidicolin. (D) Relative frequency of number of foci per individual cell. All error bars represent standard deviation (SD). n ≥ 3 experiments, t-test are performed in comparison to control without aphidicolin. ***Significantly different, P < 0.001; **Significantly different, P < 0.01; *Significantly different, P < 0.05.
Figure 4.In vivo localization of GFP-labeled Hef in response to DNA damaging agents. A total of 3049 spots within 1492 HU-treated cells and 2738 spots within 1011 MMC-cells were analyzed. (A) Pictures of DIC and GFP signal of HvRL37 cells under control conditions and after exposure to 0.075 µg/ml MMC or 5 mM HU. Bar equals 10 µm. (B) Surviving fractions in response to exposure to drugs. (C) Average cell surface of HvRL37 in response to drug exposure. (D) Mean number of GFP-Hef labeled fluorescence foci in HvRL37 cells in response to exposure to drugs. All error bars represent SD. n ≥ 3 experiments, t-test are performed in comparison to control without aphidicolin. *Significantly different, P < 0.05.
Figure 5.In vivo localization of GFP-labeled Hef in response to aphidicolin exposure in absence of Hjc. (A) Fraction of living cells in response to 5 µg/ml aphidicolin exposure. (B) DIC and GFP signal of hef+::gfp+Δhjc (HvRL61) cells under control conditions and after exposure to 5 µg/ml aphidicolin. Bar equals 10 µm. (C) Average cell surface of hef+::gfp+Δhjc cells in response to 5 µg/ml aphidicolin exposure. (D) Mean number of GFP-Hef labeled fluorescence foci in hef+::gfp+Δhjc cells in response to 5 µg/ml aphidicolin exposure. All error bars represent SD. n ≥ 3 experiments.
Figure 6.Dynamic localization of GFP-labeled Hef molecules at fluorescence foci. (A) Images of a representative cell in response to aphidicolin treatment for FRAP analysis. FRAP regions are shown by white circles. Time after photobleaching in seconds. Bar equals 5 µm. (B) Fluorescence recovery curve averaged for 9 control cells. Root-mean-square error (RMSE) = 0.0300 (C) Fluorescence recovery curve averaged for eight aphidicolin-treated cells. RMSE = 0.0155. (D) Diffusion constants (Confidence interval at 95%) calculated for GFP-labeled Hef diffusing molecules. (E) Images of representative cells for N&B analysis. Average intensity (A and C) and pseudo-coloured normalized brightness values (B and D) for representative control cells (A and B) and cells exposed to 5 µg/ml aphidicolin (C and D). Bar equals 5 µm. (F) Summary of results of N&B analysis ( ± SEM).
Figure 7.Model for replication restart in H.volcanii. Two alternative pathways allow replication restart: one is dependent on the homologous recombination proteins Hjc and RadA (pathway on the right) and one is independent of homologous recombination (pathway on the left). Our data show that Hef has a dominant role during replication restart, even in the presence of Hjc, and are also compatible with Hef, preventing the access of recombination proteins at arrested forks.